To lower drug prices, White House takes new aim at pharma patents
WASHINGTON — The White House is throwing its support behind a controversial authority that allows the government to claw back patents for certain high-priced medicines,
WASHINGTON — The White House is throwing its support behind a controversial authority that allows the government to claw back patents for certain high-priced medicines,
Abbvie announced Wednesday that it will purchase Cerevel Therapeutics and its pipeline of experimental neurological and psychiatric medications for $8.7 billion. The deal marks the
The New England Journal of Medicine, the world’s oldest continually published medical journal, publicly reckoned with its history and complicity surrounding slavery and racism Wednesday,
Ready to step outside the box and embrace the unconventional? This year’s holiday gift guide celebrates psychedelics and nods to those who appreciate the profound
I arrived in Miami last Wednesday, ready for a few days of bright colors, passionate conversations, and mind-manifesting ideas. Psychedelic Week was in full swing,
Stephen Hemsley, the board chair and former CEO of UnitedHealth Group, has sold nearly $113 million worth of company stock since the middle of October,
You’ve been asking where Payton has been, so we listened! On today’s exciting episode of The Dales Report Exclusive, we have the CEO of Numinus
1. Clinical trials Clinical trials are studies designed by experts from the fields of Neuroscience, Psychology and other areas of the biomedical sector. They measure
Visits to see loved ones in care homes, hospitals and hospices will be better protected under plans announced by the government.
For many in America, especially people in the middle class, old age is a daily struggle to keep up with basic activities.